Markus F. Scheerer

2.0k citations
39 papers · 846 · 1 hit paper · h-index 19

Impact in

Papers in

Markus F. Scheerer

36 papers receiving 834 citations

Markus F. Scheerer's Hit Papers

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes 2025 · 74 citations
740Years since publication204060

Peers

Markus F. Scheerer
Comparison fields: 5 of 63
  • Endocrinology, Diabetes and Metabolism 480
  • Nephrology 64
  • Surgery 195
  • Cardiology and Cardiovascular Medicine 97
  • Ophthalmology 25
Replace Christoph Hasslacher with:
Christoph Hasslacher Germany
Agnes Bosch Germany
Kristina Striepe Germany
Y Ohkubo Japan
Smail Messaoudi France
Norm Rosenthal United States
K. Py�r�l� Finland
Samy Hadjadj France
Минара Шамхаловна Шамхалова Russia
Claire C. J. Dekkers Netherlands
Markus F. Scheerer relative to Christoph Hasslacher Germany Christoph Hasslacher's profile →
Citations per field
00.5×10×16.9×
Christoph Hasslacher · 1×
Citations per year

Countries citing papers authored by Markus F. Scheerer

Since Specialization
Citations

This map shows the geographic impact of Markus F. Scheerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus F. Scheerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus F. Scheerer more than expected).

Fields of papers citing papers by Markus F. Scheerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus F. Scheerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus F. Scheerer. The network helps show where Markus F. Scheerer may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus F. Scheerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus F. Scheerer Line = papers co-authored together Markus F. Scheerer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2021107
2
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
Hit paper breakdown →
202574
3 202057
4 202049
5 202247
6 202044
7 202041
8 201337
9 202136
10 202035
11 202331
12 202431
13 201730
14 201430
15 202027
16 202427
17 202025
18 201425
19 201622
20 202114

About Markus F. Scheerer

Markus F. Scheerer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 846 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (7 papers), Hormonal Regulation and Hypertension (7 papers), Metabolism, Diabetes, and Cancer (5 papers), Diabetes Management and Research (4 papers), Heart Failure Treatment and Management (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (480 citations), Nephrology (64 citations), Surgery (195 citations), Cardiology and Cardiovascular Medicine (97 citations) and Ophthalmology (25 citations). Markus F. Scheerer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter Rossing, Moshe Phillip, Chantal Mathieu, Charlie Scott, Fredrik Thorén, Paresh Dandona, Bertram Pitt, Rajiv Agarwal, Amer Joseph and George L. Bakris. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Journal of the American College of Cardiology, Journal of the American Society of Nephrology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact